EGFR and neoplasm: Finally, Hashemkhani and co-workers investigated the use of cetuximab-conjugated Ag2S QDs for the delivery of 5-FU and 5-aminolevulinic acid (ALA) to achieve tumor-specific image-guided photodynamic therapy/chemotherapy combination in EGFR-overexpressing CRC cell lines.